secwatch.observer — SEC 8-K summary
======================================

Issuer:     Roivant Sciences Ltd. (ROIV)
CIK:        0001635088
Form:       8-K
Filed at:   2024-09-16T23:59:59+00:00
Accession:  0001140361-24-041188
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Roivant shareholders re-elect three Class III directors, ratify EY auditor, approve say-on-pay annually
--------------------------------------------------------------------------------

- Directors Ilan Oren, James Momtazee, Dr. Mayukh Sukhatme re-elected with 68%-92% of votes cast.
- Ernst & Young ratified as independent auditor for FY2025; 679M for, 0.8M against.
- Non-binding advisory vote on executive compensation approved: 540M for, 64.5M against.
- Advisory vote frequency set to every one year (600.7M votes); company will hold annual say-on-pay votes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1635088/000114036124041188/0001140361-24-041188-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1635088/000114036124041188/ef20035923_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-041188

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer